Gregory Stallworth
Emergency Medicine · Holly Springs, MSNPI 1043314057
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 128 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 23.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $458 and has fallen 67.7% since, to $148 in 2025. Among emergency medicine clinicians in MS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 128 payments — averaging $15.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$470
- Johnson & Johnson$261
- AstraZeneca$247
- Novartis$221
- Bayer$221
- Abbott$140
- plus $479 from 13 others
What the payments were for
- Food & beverage$2,040100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 32 | $470 |
| Johnson & Johnson(2 entities) | 18 | $261 |
| AstraZeneca | 15 | $247 |
| Novartis | 15 | $221 |
| Bayer | 13 | $221 |
| Abbott | 8 | $140 |
| Amarin Pharma, Inc. | 3 | $66 |
| AbbVie(2 entities) | 3 | $65 |
| Sunovion Pharmaceuticals Inc. | 4 | $60 |
| Kowa Pharmaceuticals America, Inc. | 2 | $53 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $53 |
| Smith+Nephew | 3 | $49 |
| Lilly USA, LLC | 3 | $38 |
| Melinta Therapeutics, LLC | 1 | $26 |
| Pacira Therapeutics, Inc. | 1 | $22 |
| Dexcom, Inc. | 1 | $14 |
| Vyera Pharmaceuticals, LLC | 1 | $11 |
| Collegium Pharmaceutical, Inc. | 1 | $11 |
| Pfizer | 1 | $11 |
How this compares
$2,040 in reported general payments places this provider in the 95th percentile of 443 emergency medicine providers in Mississippi.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 41 | $48,494 |
| LinzessLinaclotide | 78 | $47,816 |
| RybelsusSemaglutide | 39 | $43,672 |
| EliquisApixaban | 55 | $37,944 |
| EntrestoSacubitril/Valsartan | 42 | $28,650 |
| VraylarCariprazine Hcl | 13 | $18,501 |
| TradjentaLinagliptin | 26 | $17,305 |
| XareltoRivaroxaban | 26 | $16,688 |
| TrintellixVortioxetine Hydrobromide | 28 | $12,858 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 32 | $11,911 |
| Tresiba Flextouch U-200Insulin Degludec | 15 | $11,637 |
| Aimovig AutoinjectorErenumab-Aooe | 13 | $9,624 |
| JardianceEmpagliflozin | 15 | $9,015 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 12 | $8,039 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 11 | $6,910 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $470 | $92,16680 claims |
| AbbVieLinzess, Vraylar | $65 | $66,31791 claims |
| PfizerEliquis | $11 | $37,94455 claims |
| NovartisEntresto | $221 | $28,65042 claims |
| Johnson & JohnsonXarelto | $261 | $16,68826 claims |
| AstraZenecaBreztri Aerosphere | $247 | $6,91011 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 443 emergency medicine providers in Mississippi.
Other emergency medicine in Holly Springs
- Stanley ThompsonSouthaven$466K
- Utsav NandiJackson$54K
- Richard SummersJackson$20K
- Damon DarseyJackson$11K
- Kenneth WhittingtonHazlehurst$8K
- Samuel Richardson IiiJackson$8K
- Joseph PongettiJackson$5K
- Robert WalkerHazlehurst$5K
- Salvador ArceoBrandon$5K
- Manuel OngCarthage$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.